Drug Profile
Research programme: peptide therapeutics - Ipsen/PeptiDream
Latest Information Update: 23 Mar 2023
Price :
$50
*
At a glance
- Originator Ipsen; PeptiDream
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Endocrine disorders
Most Recent Events
- 23 Mar 2023 Discontinued - Preclinical for Cancer in France (Parenteral)
- 23 Mar 2023 Discontinued - Preclinical for Cancer in Japan (Parenteral)
- 23 Mar 2023 Discontinued - Preclinical for Endocrine disorders in France (Parenteral)